World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   23424 records for 4604 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02528747
A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate
06/08/2015
AuthorisedEUCTR2015-000424-28-ES
A study to assess the efficacy and safety of tocilizumab versus placebo in patients with Systemic Sclerosis.
04/08/2015
AuthorisedEUCTR2013-002549-12-ES
PHASE 3, MULTICENTER, LONG-TERM OBSERVATIONAL STUDY OF SUBJECTS FROM TANEZUMAB STUDIES WHO UNDERGO A TOTAL KNEE, HIP OR SHOULDER REPLACEMENT
31/07/2015
AuthorisedEUCTR2014-003863-40-ES
Study of MEDI4736 monotherapy and MEDI4736 in combination with Tremelimumab versus Standard of Care Therapy in patients with SCCHN
31/07/2015
Not recruitingNCT02511106
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy
28/07/2015
RecruitingNCT02510092
Coronary Artery and Systemic Autoimmune Disease: Diagnostics and Treatment
23/07/2015
RecruitingNCT02513927
The Effects of Different Kinds of Antihypertensive Drugs on Blood Pressure Variability in Northern Chinese
21/07/2015
Not recruitingNCT02497716
Phase I Study on Rivaroxaban Dry Powder Suspension in Children
12/07/2015
Not RecruitingCTRI/2015/07/005991
A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI)and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer
10-07-2015
AuthorisedEUCTR2015-000634-29-ES
A Study of Alectinib versus Pemetrexed or Docetaxel in Patients with Anaplastic Lymphoma Kinase-Positive Advanced Non Small Cell Lung Cancer
10/07/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history